Research has suggested that interferon gamma (IFN-γ), an immune potentiating agent, favours activation of mitochondrial-operated apoptotic pathway in breast cancer cell lines by interacting with its receptor, interferon gamma receptor 1 (IFNGR1) [21]. This evidence concerns the gene IFNG and breast carcinoma.